Vertex and Obsidian Therapeutics Establish Collaboration to Discover Novel Therapies That Regulate Gene Editing
Vertex Pharmaceuticals Incorporated and Obsidian Therapeutics announced today that the two companies have entered into a ...
Read moreVertex Pharmaceuticals Incorporated and Obsidian Therapeutics announced today that the two companies have entered into a ...
Read more- Under terms of amended agreement, Vertex to lead worldwide development, manufacturing and commercialization of CTX001- ...
Read more- If approved, people ages 12 years and older who have one copy of the F508del mutation ...
Read moreVertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the Australian Therapeutic Goods Administration (TGA) has approved ...
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.